These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36104450)

  • 1. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
    van de Vusse D; Mian P; Schoenmakers S; Flint RB; Visser W; Allegaert K; Versmissen J
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1763-1776. PubMed ID: 36104450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
    BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
    Shekhar S; Gupta N; Kirubakaran R; Pareek P
    BJOG; 2016 Jan; 123(1):40-7. PubMed ID: 26113232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
    Clark SM; Dunn HE; Hankins GD
    Semin Perinatol; 2015 Nov; 39(7):548-55. PubMed ID: 26344738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
    Salama M; Rezk M; Gaber W; Hamza H; Marawan H; Gamal A; Abdallah S
    Pregnancy Hypertens; 2019 Jul; 17():54-58. PubMed ID: 31487657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension.
    Sanusi AA; Leach J; Boggess K; Dugoff L; Sibai B; Lawrence K; Hughes BL; Bell J; Aagaard K; Edwards RK; Gibson KS; Haas DM; Plante L; Metz TD; Casey B; Esplin S; Longo S; Hoffman MK; Saade GR; Hoppe KK; Foroutan J; Tuuli M; Owens MY; Simhan HN; Frey H; Rosen T; Palatnik A; Baker S; August P; Reddy UM; Su EJ; Krishna I; Nguyen NA; Norton ME; Skupski D; El-Sayed YY; Ogunyemi D; Galis ZS; Harper L; Ambalavanan N; Geller NL; Kuo HC; Sinkey RG; Librizzi R; Pereira L; Magann EF; Habli M; Williams S; Mari G; Pridjian G; McKenna DS; Parrish M; Chang E; Osmundson S; Quinones J; Szychowski JM; Tita ATN
    Obstet Gynecol; 2024 Jul; 144(1):126-134. PubMed ID: 38949541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription.
    Mitro SD; Hedderson M; Xu F; Forquer H; Baker JM; Kuzniewicz MW; Greenberg M
    Am J Obstet Gynecol; 2024 Oct; 231(4):456.e1-456.e13. PubMed ID: 38280432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.
    Mulrenin IR; Garcia JE; Fashe MM; Loop MS; Daubert MA; Urrutia RP; Lee CR
    Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1261-1279. PubMed ID: 34739303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "Preeclampsia and Hypertension Target Treatment" study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings.
    di Pasquo E; Giannubilo SR; Valentini B; Salvi S; Rullo R; Fruci S; Filippi E; Ornaghi S; Zullino S; Rossi F; Farsetti D; Di Martino DD; Vasapollo B; Locatelli A; De Santis M; Ciavattini A; Lanzone A; Mecacci F; Ferrazzi E; Valensise H; Ghi T
    Am J Obstet Gynecol MFM; 2024 May; 6(5):101368. PubMed ID: 38574856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
    Dublin S; Idu A; Avalos LA; Cheetham TC; Easterling TR; Chen L; Holt VL; Nance N; Bider-Canfield Z; Neugebauer RS; Reynolds K; Badon SE; Shortreed SM
    PLoS One; 2022; 17(5):e0268284. PubMed ID: 35576217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
    Rezk M; Emarh M; Masood A; Dawood R; El-Shamy E; Gamal A; Badr H
    Hypertens Pregnancy; 2020 Nov; 39(4):393-398. PubMed ID: 32697618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and Pregnancy: Management and Future Risks.
    Reddy S; Jim B
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):137-145. PubMed ID: 31023448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current perspective of treating hypertension in pregnancy].
    Koucký M
    Vnitr Lek; 2011 Sep; 57(9):728-31. PubMed ID: 21957765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.